Rh2(S-PTAD)4
CAS: 909389-99-7
Ref. 3D-JLB38999
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire | |
| 500mg | To inquire |
Product Information
- Tetrakis[(S)-(+)-(1-adamantyl)-(N-phthalimido)acetato]dirhodium(II)Rh2(S-PTAD)4
Rh2(S-PTAD)4 is a ligand that is activated by the addition of an electron. The asymmetric synthesis of this molecule has been accomplished by using a model system, in which a vinyl ether was used as a precursor to produce the ligand. Hydride transfer was then used to synthesize the necessary dihydropyridazine rings. X-ray analysis revealed that Rh2(S-PTAD)4 has stereogenic centers and functional theory calculations confirmed that it can be considered a chiral ligand in its enantiomeric form. Synthesis of this molecule was achieved through an isolated yield and tetrahydropyridazine as starting material.
Chemical properties
Technical inquiry about: 3D-JLB38999 Rh2(S-PTAD)4
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
